海外の治験の状況「前立腺癌」での検索結果
1909件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer
- Belgium, Spain
- 2016-11-21
Authorised
- An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer
- PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Denmark, France, Germany, Netherlands, Sweden, United Kingdom, United States
- 2018-06-29
Not Recruiting
- Cell-derived vesicles as diagnostic instrument for prostate cancer.
- prostate cancer
- The Netherlands
- 2018-06-08
Not Recruiting
- Salvage lymphadenectomy with or without adjuvant radiation therapy for prostate cancer recurrence
- Prostate Carcinoma, Salvage lymphadenectomy;C61 - Malignant neoplasm of prostate
- Germany
- 2018-05-15
Recruiting
- Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
- Prostate Cancer
- Belgium, Canada, Denmark, France, Netherlands, Puerto Rico, Sweden, United Kingdom, United States
- 2018-04-13
Not recruiting
- Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
- Castration-resistant Prostate Cancer
- United Kingdom
- 2018-03-12
Recruiting
- Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)
- Metastatic Castration Resistant Prostate Cancer;68Ga-PSMA PET/CT Positive;Metastatic Castration Resistant Prostate Cancer;68Ga-PSMA PET/CT Positive;Metastatic Castration Resistant Prostate Cancer;68Ga-PSMA PET/CT Positive
- Italy
- 2018-02-27
Authorised
- 68Ga-RM2 compared to 68Ga-PSMA-617 PET/CT for prostate cancer imaging according to various metastatic risks “UROPET”
- Prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- France
- 2018-02-27
Recruiting
- Prostatic Artery Embolization in Advanced Prostate Cancer
- Prostate Cancer;Bladder Outlet Obstruction;Prostate Cancer;Bladder Outlet Obstruction;Prostate Cancer;Bladder Outlet Obstruction
- Switzerland
- 2018-02-22
Recruiting
- Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer
- Prostate Cancer Recurrent;Prostate Cancer Recurrent;Prostate Cancer Recurrent
- France
- 2018-02-16
